Background -Cryptogenic fibrosing alveolitis (synonymous with idiopathic pulmonary fibrosis) is a clinically heterogeneous condition in which the precipitating factor is unclear. Both environmental and infective factors have been implicated. An association between Epstein-Barr virus (EBV) and cryptogenic fibrosing alveolitis was suggested over a decade ago by a study based on EBV serology, but the significance of this has been unclear. Methods -Lung tissue obtained surgically from patients (n = 20) with cryptogenic fibrosing alveolitis was investigated for evidence ofEBV replication and compared with lung tissue from 21 control patients. Fourteen ofthe 20 patients had received no specific therapy for cryptogenic fibrosing alveolitis at the time ofbiopsy. Monoclonal antibodies directed against the EBV viral antigens, EBV viral capsid antigen (VCA) and gp 3401220 antigen, which are ex-
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Results -Fourteen (70%) ofthe 20 patients with cryptogenic fibrosing alveolitis were positive for both EBV VCA and gp 340/220 compared with two (9%) ofthe positive for gp 340/200 and VCA were scored as follows: " + " = staining restricted to one or two patches within the section or "+ +" = multiple patches of intense staining throughout the biopsy specimen.
DATA ANALYSIS
The proportion of patients in each group with positive staining for EBV was compared using Fisher's exact test. The two tailed probability (by summation) p value is quoted. Significance was set at the 5% level.
Results
All the patients in the cryptogenic fibrosing alveolitis group had typical histological features of cryptogenic fibrosing alveolitis (table 1) . Two patients (nos 10 and 11) were ex-coal miners but neither had histological evidence of pneumoconiosis; two (nos 12 and 13) gave an occupational history of brief asbestos exposure which was not deemed to be clinically important and in neither patient was there con- comitant radiological (plaques) or histological (asbestos bodies, pleural fibrosis) evidence of asbestos-related disease; one other patient (no. 14) had significant occupational asbestos exposure but as no asbestos bodies were identified histologically he was characterised as having cryptogenic fibrosing alveolitis. Fourteen of the 20 patients with cryptogenic fibrosing alveolitis had never received immunosuppression before the acquisition of lung tissue. The remaining six patients had received a combination of either prednisolone, azathioprine, cyclophosphamide, and cyclosporin (table 2) . Asbestos bodies were not identified in any biopsy specimen.
In the control group, of the 14 cases whose tissue blocks were taken from a malignancy, the histological examination was completely normal in eight patients and showed a minor degree of emphysema in six ( 
